论文部分内容阅读
随着脑梗塞诊断治疗的不断深入研究,人们越来越重视脑梗塞治疗前后的血液流变学变化,作者用重庆制药厂生产的前列腺素E_1(PGE_1)和紫外线照射自血回输疗法(VBI)联合治疗脑梗塞30例,取得十分满意的效果,并分析其对血液流变学的影响。现报告如下。1 材料和方法1.1 一般资料 本组共60例,随机分为PGE_1+VBI治疗组和低分子有旋糖酐对照组各30例。所有病例均经临床及头颅CT扫描确诊,(1986年中华医学会第二届全国脑血管病学术会议修订的诊断标准)。治疗组中男20例,女10例,年龄50—83岁,平均65.5岁;对照组中,男22例,女8例,年龄51—79岁,平均66.1岁。两组患者的性别、年龄、梗塞部位,病灶大小等基本相似(P>0.05),具有可比性。
With the continuous deepening research on the diagnosis and treatment of cerebral infarction, people pay more and more attention to the changes of hemorheology before and after the treatment of cerebral infarction. The author used the prostaglandin E_1 (PGE_1) produced by Chongqing Pharmaceutical Factory and the ultraviolet ray autotransfusion therapy (VBI ) Combined treatment of cerebral infarction in 30 cases, obtained very satisfactory results, and analyze its impact on hemorheology. The report is as follows. 1 Materials and Methods 1.1 General Information The group of 60 patients were randomly divided into PGE_1 + VBI treatment group and the low molecular weight of the control group of 30 cases. All cases were confirmed by clinical and cranial CT scan (1986 Chinese Medical Association Second National Cerebrovascular Disease Conference revised diagnostic criteria). Treatment group, 20 males and 10 females, aged 50-83 years, an average of 65.5 years; control group, 22 males and 8 females, aged 51-79 years, mean 66.1 years. The two groups of patients were similar in gender, age, infarct size and size (P> 0.05).